BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29695918)

  • 1. Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma.
    Huang C; Huang Z; Zhao X; Wang Y; Zhao H; Zhong Z; Wang L
    Onco Targets Ther; 2018; 11():2111-2120. PubMed ID: 29695918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
    Liu F; Zhang Y; Peng Z; Gao H; Xu L; Chen M
    J Transl Med; 2012 Jul; 10():135. PubMed ID: 22747650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder.
    Liu JY; Li YH; Lin HX; Liao YJ; Mai SJ; Liu ZW; Zhang ZL; Jiang LJ; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
    BMC Cancer; 2013 Jul; 13():349. PubMed ID: 23870412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
    Zhu J; Lu Z; Ke M; Cai X
    Int Urol Nephrol; 2022 Jul; 54(7):1505-1512. PubMed ID: 35467245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
    Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
    Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Checkpoint Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 is Upregulated and Independently Predicts Unfavorable Prognosis in Bladder Urothelial Carcinoma.
    Lin G; Ye H; Wang J; Chen S; Chen X; Zhang C
    Nephron; 2019; 141(4):256-264. PubMed ID: 30602154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
    Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
    Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.
    Liu J; Cai M; Chen J; Liao Y; Mai S; Li Y; Huang X; Liu Y; Zhang J; Kung H; Zeng Y; Zhou F; Xie D
    Eur J Cancer; 2014 Mar; 50(4):840-51. PubMed ID: 24388773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
    Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
    BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Arp2 expression is associated with the prognosis and prediction of lymph node metastasis in bladder urothelial carcinoma.
    Xu N; Qu GY; Wu YP; Li XD; Lin MY; Chen SH; Xue XY; Wei Y
    Cancer Manag Res; 2018; 10():503-511. PubMed ID: 29593429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of Tat-interacting Protein 30 Expression Could be a Prognostic Marker in Bladder Urothelial Cancer.
    Li YP; Zhu JF; Huang KT; Wang RR; Cai B; Xie H; Chen HD
    Chin Med J (Engl); 2018 Jan; 131(2):188-193. PubMed ID: 29336367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis.
    Huang C; Huang Z; Bai P; Luo G; Zhao X; Wang X
    Onco Targets Ther; 2018; 11():2075-2082. PubMed ID: 29695915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated preoperative plasma fibrinogen level is an independent predictor of malignancy and advanced stage disease in patients with bladder urothelial tumors.
    Liu J; Li D; Cao L; Wang Z; Li Y; Liu H; Chen G
    Int J Surg; 2016 Dec; 36(Pt A):249-254. PubMed ID: 27826047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance.
    Tang X; Xing J; Li W; Wu Z; Zhang K; Zheng J
    J BUON; 2013; 18(1):211-9. PubMed ID: 23613408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chronic obstructive pulmonary disease negatively influences the prognosis of patients with bladder urothelial carcinoma via hypoxia inducible factor-1α.
    Huang Z; Xu R; Lv C; Zhong Z; Zhang L; Zhu L; Tang Y; Zhao X
    Int J Clin Exp Med; 2014; 7(10):3344-53. PubMed ID: 25419367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.
    Yan Y; Yang FQ; Zhang HM; Li J; Li W; Wang GC; Che JP; Zheng JH; Liu M
    Int J Clin Exp Pathol; 2014; 7(7):4231-8. PubMed ID: 25120803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer.
    Yang GL; Zhang LH; Bo JJ; Huo XJ; Chen HG; Cao M; Liu DM; Huang YR
    J Surg Oncol; 2012 Jul; 106(1):57-61. PubMed ID: 22237993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.
    Wu T; Zhang W; Yang G; Li H; Chen Q; Song R; Zhao L
    Oncotarget; 2016 Aug; 7(31):50417-50427. PubMed ID: 27391431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant Prognostic Value of the Autophagy-Related Gene P4HB in Bladder Urothelial Carcinoma.
    Lyu L; Xiang W; Zheng F; Huang T; Feng Y; Yuan J; Zhang C
    Front Oncol; 2020; 10():1613. PubMed ID: 32903592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.